Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
incontinence
MedTech
JPM24: Boston Scientific drops $3.7B on neuromod player Axonics
Boston Scientific will acquire Axonics in a $3.7 billion deal, gaining the developer of neurostimulation therapies for urinary and fecal incontinence.
Conor Hale
Jan 8, 2024 10:12am
Amber Therapeutics acquires neuromod implant maker Bioinduction
Sep 5, 2023 10:45am
BlueWind nabs de novo nod for incontinence neuromod system
Aug 17, 2023 10:22am
FDA OKs Axonics' latest 20-year rechargeable neurostimulator
Jan 31, 2023 12:09pm
Axonics nabs Canadian OK for updated 20-year neurostim implant
Dec 14, 2022 12:28pm
Renovia's digital exercise app cleared for fecal incontinence
Jul 11, 2022 8:51am